Spring 2026 Customer to Capital Accelerator: Founders Building the Future at Scale
From AI that accelerates risk detection to medical devices redefining patient care, and energy technologies that recharge what’s possible, this cohort is tackling problems that have long resisted change.
The startups are entering Rev1’s Customer to Capital Accelerator with validated technologies, early customer traction, and the ambition to scale. Across enterprise SaaS, advanced technologies, healthcare IT, and medical devices, their solutions are already being deployed in the real world, improving safety, efficiency, access, and outcomes.
The future of these industries isn’t on a distant roadmap. It’s being built now, and taking off right here in Columbus.
The Customer to Capital Accelerator, is a 14-week program designed for founders who have moved beyond ideation and product-market fit exploration and are ready to accelerate revenue, refine their go-to-market strategy, and prepare for institutional capital. This cohort represents what’s possible when technical depth meets execution discipline.
Meet the Spring 2026 Cohort
Daimo Medical: Creating a novel ventricular reshaping device that reduces left ventricular volume and corrects mitral regurgitation through a minimally invasive transcatheter approach.
Empower Battery Technology: Developed a patented glass anode enabling batteries to fully charge in minutes, including in cold temperatures. The domestically produced material replaces graphite and drops into existing battery manufacturing.
GradLinks: K-12 platform that empowers school districts to track students’ progress to graduation and connect them with career opportunities via web-based applications.
Inviprium Medical: Reducing pain during IUD placement with a single-step, IR-guided inserter.
Kyros Innovations: Public-safety company delivering edge-deployable software to support safer operations for first-responders under degraded conditions.
LAACClamp: Developing a device that conforms to the base of the left atrial appendage to enable full closure, prevent blood clots, reduce risk of stroke with a proprietary delivery system that is intuitive and has a low profile.
My Autonomous Transportation Co.: Infrastructure for the scaling and daily operations of driverless fleets.
SuppTrax: B2B SaaS platform that transforms insurance supplements into measurable, repeatable revenue for contractors.
Vosmosis: VR and AI-powered teaching tools to create real-world immersion experiences helping users learn languages faster than traditional memorization-based apps.
Built for Founders Ready for What’s Next
Scaling a company requires more than a strong product, it demands customers, capital readiness, and operational clarity.
Over 14 weeks, the Customer to Capital Accelerator supports founders as they:
- Secure and expand early customers
- Strengthen positioning and competitive advantage
- Build financial and capital strategies for growth
- Develop and refine an investor-ready pitch
This is not a program for experimentation. It’s for founders who are building companies meant to win. If you’ve validated your solution and are ready to scale with intention, this program turns that momentum into proven acceleration.
Interested in learning more? https://www.rev1ventures.com/customer-to-capital/
